Condition
Functional Disorder
Total Trials
5
Recruiting
1
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Active Not Recruiting2
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07272148Active Not Recruiting
The Pilot of the Turku Outpatient Clinic for Functional and Fatigue Disorders
NCT04935307Not ApplicableActive Not RecruitingPrimary
Central Processing of Odour Stimuli in Patients With Functional Somatic Disorder, MCS or Post Covid Compared to Healthy Controls
NCT06232473Phase 4RecruitingPrimary
Patient Education and Duloxetine, Alone and in Combination, for Patients With Multisystem Functional Somatic Disorder
NCT04464447Not ApplicableCompletedPrimary
Feasibility and Pilot Testing of Group-based ACT for Adolescents With Functional Somatic Syndromes
NCT03694769CompletedPrimary
Investigating Drop Attacks
Showing all 5 trials